MedPath
NMPA Approval

Ritonavir Tablets

国药准字H20234359

October 24, 2023

Drug Information

利托那韦片

片剂

100mg

化学药品

October 24, 2023

Company Information

Applicant Company

广东省东莞市松山湖园区工业北路1号

Manufacturing Company

广东省韶关市乳源瑶族自治县乳城镇侯公渡龙船湾下坝开发区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利托那韦片 - NMPA 批准文号 | MedPath